Renikzon

General characteristics. Structure:

Active ingredients: 680 mg of calcium of a carbonate, 80 mg of magnesium of a carbonate, 750 mg of starch syrup.

Excipients: granulated sugar, calcium stearate, potato starch, talc, menthol.

The drug used at the states connected with acidity disturbance.

Indications to use:

The symptoms caused by a hyperoxemia of a gastric juice (hyperacidity): heartburn, feeling of overflow or weight in epigastric area, a meteorism, nausea, an acid eructation. Sensations of discomfort in a stomach as a result of errors in a diet, drug intake, an alcohol abuse, coffee, nicotine.

Route of administration and doses:

Adults and children are more senior than 12 years: on 1-2 tablets to chew (or to hold in a mouth to a full rassasyvaniye). If necessary it is possible to repeat reception of medicine in 2 hours. The maximum daily dose – 16 tablets. Children aged up to 12 years apply only on doctor's orders.

Features of use:

It is not intended for prolonged use. With care it is necessary to apply during pregnancy and when breastfeeding.

Instruction sick diabetes mellitus: 1 tablet contains 475 mg of sugar.

Side effects:

Allergic reactions, diarrhea, gipermagnemiya and hypercalcemia are possible (at patients with a renal failure). At use of medicine in high doses within several hours from the moment of the last reception compensation hypersecretion of a gastric juice can be observed.

Interaction with other medicines:

At simultaneous use reduces absorption of indometacin, salicylates, Chlorpromazinum, Phenytoinum, blockers of H2-histamine receptors of beta adrenoblockers, a diflunizal, an isoniazid, digoxin, tetracyclines, indirect anticoagulants, barbiturates, iron preparations (the listed medicines should be applied in 1 hour prior to or in 1 hour after reception). Anticholinergic medicines strengthen and extend action, slowing down gastric emptying. Strengthens effect of Sulfadiazinum, levodopa, acetylsalicylic acid and Acidum nalidixicum.

Contraindications:

Severe forms of a renal failure, hypercalcemia, hypersensitivity to medicine components, a myasthenia.

Overdose:

Preferential at patients with a renal failure, long reception of high doses of drug can lead to a renal failure, a gipermagniyemiya, a hypercalcemia and an alkalosis that can provoke emergence of symptoms from digestive tract (nausea, a lock, vomiting) and muscular weakness. In that case it is necessary to stop administration of drug and to accept enough liquid. In hard cases of overdose (for example, a milk and alkaline syndrome) it is necessary to consult with the doctor as additional measures for recovery of a water balance can be required.

Storage conditions:

In the place protected from light and moisture at a temperature from 10 °C to 25 °C. To store in the place, unavailable to children. Period of validity 3 years. Not to use after the term specified on packaging.

Issue conditions:

Without recipe

Packaging:

Place on the 24th chewable tablets in bank polymeric with the cover tense with control of the first opening for medicines or 12 chewable tablets in a blister strip packaging from packaging of the blister of polymeric materials and aluminum foil.

Each can or 2 blister strip packagings together with a leaf insert are placed in secondary packaging (a pack from a cardboard bandbox).